Chapuy, Bjoern <br/><br/>
Multikinase inhibitor sorafenib exerts cytocidal efficacy against Non-Hodgkin lymphomas associated with inhibition of MAPK14 and AKT phosphorylation.  [electronic resource] 

 -  British journal of haematology  Feb 2011 
 - 401-12 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1365-2141 
<br/><br/><label>Standard No.: </label>10.1111/j.1365-2141.2010.08526.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--pharmacology<br/>Apoptosis--drug effects<br/>Benzenesulfonates--pharmacology<br/>Cell Cycle--drug effects<br/>Cell Death--drug effects<br/>Cell Proliferation--drug effects<br/>Dose-Response Relationship, Drug<br/>Drug Evaluation, Preclinical--methods<br/>Humans<br/>Lymphoma, Non-Hodgkin--drug therapy<br/>Mitogen-Activated Protein Kinase 14--antagonists & inhibitors<br/>Niacinamide--analogs & derivatives<br/>Phenylurea Compounds<br/>Phosphorylation<br/>Protein Kinase Inhibitors--pharmacology<br/>Proto-Oncogene Proteins c-akt--antagonists & inhibitors<br/>Pyridines--pharmacology<br/>Signal Transduction--drug effects<br/>Sorafenib<br/>Tumor Cells, Cultured<br/>Tumor Stem Cell Assay--methods